Litcius/Paper detail

Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial

Ming-Ming He, Zhiqiang Wang, Jin Lu, Yuxian Bai, Teng Mao, Jun Wang, Qing-Xia Fan, X.-C. Zhang, Kuaile Zhao, Zhendong Chen, Shegan Gao, Jiancheng Li, Zhichao Fu, Kangsheng Gu, Zhihua Liu, Lin Wu, Xiaodong Zhang, Jifeng Feng, Zuoxing Niu, Yi Ba, Helong Zhang, Ying Liu, Li Zhang, Xuhong Min, Jing Huang, Ying Cheng, Dong Wang, Zhen Sheng, Wanqin Zeng, Song Li, Rui‐Hua Xu, Hui Luo

2024Med28 citationsDOIOpen Access PDF

Topics & Concepts

MedicineChemotherapyOncologyInterim analysisInternal medicineOverall survivalEsophageal squamous cell carcinomaBasal cellProgression-free survivalCarcinomaRandomized controlled trialEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial | Litcius